Research allows for increased patient treatment options, improved patient outcomes, and better service. All patients who are eligible will have the opportunity to be part of leading and innovative research. We are one of a small number of hospital trusts who offer national and commercial studies underpinned by the National Institute for Health Research (NIHR).Â
Endometriosis research studies
ESPriT2 study – Laparoscopy for suspected endometriosis
The study aims to find out the effectiveness of laparoscopic removal of isolated superficial peritoneal endometriosis for the management of chronic pelvic pain in women.
For more information, please contact the research team or visit:
REGAL study – Recurrence of endometriosis
Regal aims to find out how best to treat those who have already had surgery for endometriosis but later experience recurrence of endometriosis pain. The trial will compare further surgery and hormonal treatment.
For more information, please contact the research team or visit:
AMY109EU study – ACERS; Assessing a new treatment Concept for EndometRioSis
The Gynaecology research team are playing a key role in leading a Phase II research study, which will evaluate an antibody designed to reduce inflammation and endometriosis symptoms. The drug was developed by scientists from Chugai Pharmaceutical Co Ltd and aims to block a protein (interleukin-8) which promotes the body’s inflammatory response to endometriosis.
The way this new, first of its kind treatment works in reducing inflammation and potentially the destructive scarring of endometriosis, could mean in the long-term some women avoid surgery for this debilitating disease.
Menopause research
POISE study
Hormone therapy for premature ovarian insufficiency (POI): a randomised trial and long-term evaluation to help treat menopausal women with either the combined pill or HRT.
For more information, please contact the research team or visit:
Our research team
- Study Lead: Dr. Dorota Hardy
- Research Nurse: Del Endersby
Contact: 0113 2066473